| scholarly article | Q13442814 |
| P50 | author | Paul E Kolenbrander | Q123166336 |
| P2093 | author name string | Michael Friedman | |
| Doron Steinberg | |||
| Gilad Bachrach | |||
| Amram Mor | |||
| Natalia I Chalmers | |||
| Hamutal Altman | |||
| Michal Gabai-Gutner | |||
| P2860 | cites work | The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface | Q24680172 |
| Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3 | Q28117302 | ||
| Antimicrobial peptides of multicellular organisms | Q28131811 | ||
| Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies | Q29617810 | ||
| Internalisation and degradation of histatin 5 by Candida albicans | Q30911101 | ||
| In vitro assessment of antimicrobial peptides as potential agents against several oral bacteria | Q33243027 | ||
| Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides | Q33855582 | ||
| In vitro activity of the histatin derivative P-113 against multidrug-resistant pathogens responsible for pneumonia in immunocompromised patients | Q33857777 | ||
| Role of the cystic fibrosis transmembrane conductance regulator in innate immunity to Pseudomonas aeruginosa infections | Q33988505 | ||
| Susceptibility of nontypeable Haemophilus influenzae to human beta-defensins is influenced by lipooligosaccharide acylation | Q34130303 | ||
| Innate immunity, antimicrobial peptides, and protection of the oral cavity | Q34155162 | ||
| The nervous system and innate immunity: the neuropeptide connection | Q34420533 | ||
| Antimicrobial peptides in defence of the oral and respiratory tracts | Q35563978 | ||
| Mechanisms of decreased susceptibility to beta-defensins by Treponema denticola | Q35784013 | ||
| Impact of LL-37 on anti-infective immunity. | Q35966461 | ||
| Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine | Q36369306 | ||
| Lipopolysaccharides from distinct pathogens induce different classes of immune responses in vivo | Q37084615 | ||
| Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids | Q37932475 | ||
| Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL-37. | Q38362260 | ||
| Microbial complexes in subgingival plaque | Q38553206 | ||
| Amphotericin B- and fluconazole-resistant Candida spp., Aspergillus fumigatus, and other newly emerging pathogenic fungi are susceptible to basic antifungal peptides | Q39470384 | ||
| ??? | Q28262177 | ||
| Antimalarial activities of dermaseptin S4 derivatives | Q39474943 | ||
| Susceptibilities of oral bacteria and yeast to mammalian cathelicidins | Q39478909 | ||
| Treponema denticola is resistant to human beta-defensins | Q39655539 | ||
| Improvement of outer membrane-permeabilizing and lipopolysaccharide-binding activities of an antimicrobial cationic peptide by C-terminal modification | Q40286592 | ||
| A molecular mechanism for lipopolysaccharide protection of Gram-negative bacteria from antimicrobial peptides. | Q40456986 | ||
| Human beta-defensins 2 and 3 demonstrate strain-selective activity against oral microorganisms | Q40638341 | ||
| Differential induction of endotoxin tolerance by lipopolysaccharides derived from Porphyromonas gingivalis and Escherichia coli | Q40773060 | ||
| Synthetic histatin analogues with broad-spectrum antimicrobial activity | Q42113164 | ||
| Staphylococcus aureus strains lacking D-alanine modifications of teichoic acids are highly susceptible to human neutrophil killing and are virulence attenuated in mice. | Q44074411 | ||
| Degradation of antimicrobial histatin-variant peptides in Staphylococcus aureus and Streptococcus mutans | Q44562211 | ||
| Multiple roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin in host defense | Q47922120 | ||
| An anti-infective peptide that selectively modulates the innate immune response | Q50072960 | ||
| In vitro discriminative antipseudomonal properties resulting from acyl substitution of N-terminal sequence of dermaseptin s4 derivatives. | Q51080439 | ||
| Modulation of antibacterial peptide activity by products of Porphyromonas gingivalis and Prevotella spp. | Q52569800 | ||
| Innate immune peptide LL-37 displays distinct expression pattern from beta-defensins in inflamed gingival tissue. | Q54576734 | ||
| Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study. | Q55036173 | ||
| Characterization of Histatin 5 with Respect to Amphipathicity, Hydrophobicity, and Effects on Cell and Mitochondrial Membrane Integrity Excludes a Candidacidal Mechanism of Pore Formation | Q60314973 | ||
| Structure-activity relationship study of antimicrobial dermaseptin S4 showing the consequences of peptide oligomerization on selective cytotoxicity | Q73413971 | ||
| Genetic analyses of proteolysis, hemoglobin binding, and hemagglutination of Porphyromonas gingivalis. Construction of mutants with a combination of rgpA, rgpB, kgp, and hagA | Q77863752 | ||
| Cutting Edge: TLR2 is required for the innate response to Porphyromonas gingivalis: activation leads to bacterial persistence and TLR2 deficiency attenuates induced alveolar bone resorption | Q79401044 | ||
| Susceptibilities of periodontopathogenic and cariogenic bacteria to antibacterial peptides, {beta}-defensins and LL37, produced by human epithelial cells | Q95798490 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antimicrobial peptide | Q1201508 |
| Porphyromonas gingivalis | Q3214147 | ||
| P304 | page(s) | 638-642 | |
| P577 | publication date | 2007-12-17 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Resistance of Porphyromonas gingivalis ATCC 33277 to direct killing by antimicrobial peptides is protease independent | |
| P478 | volume | 52 |
| Q34044666 | Actin enables the antimicrobial action of LL-37 peptide in the presence of microbial proteases |
| Q38659649 | Anaerobic bacteria growth in the presence of cathelicidin LL-37 and selected ceragenins delivered as magnetic nanoparticles cargo. |
| Q26991811 | Antibiotic development challenges: the various mechanisms of action of antimicrobial peptides and of bacterial resistance |
| Q36720179 | Bacterial Evasion of Host Antimicrobial Peptide Defenses |
| Q36241951 | Chemokine guidance of central memory T cells is critical for antiviral recall responses in lymph nodes. |
| Q35003110 | Corruption of innate immunity by bacterial proteases |
| Q84019757 | Degradation of human alpha- and beta-defensins by culture supernatants of Porphyromonas gingivalis strain 381 |
| Q40394569 | Experimental Induction of Bacterial Resistance to the Antimicrobial Peptide Tachyplesin I and Investigation of the Resistance Mechanisms |
| Q35867824 | Influence of saliva on the oral microbiota |
| Q42086240 | Inhibitory effects of lactoferrin on growth and biofilm formation of Porphyromonas gingivalis and Prevotella intermedia |
| Q34441271 | Isomerization of an antimicrobial peptide broadens antimicrobial spectrum to gram-positive bacterial pathogens |
| Q34952815 | LL-37 in periodontal health and disease and its susceptibility to degradation by proteinases present in gingival crevicular fluid |
| Q38365016 | P. gingivalis in Periodontal Disease and Atherosclerosis - Scenes of Action for Antimicrobial Peptides and Complement |
| Q92471578 | Peptide and non-peptide mimetics as potential therapeutics targeting oral bacteria and oral biofilms |
| Q90133643 | Potential Oral Health Care Agent from Coffee Against Virulence Factor of Periodontitis |
| Q42078203 | Saliva enables the antimicrobial activity of LL-37 in the presence of proteases of Porphyromonas gingivalis |
| Q42264548 | The antibacterial activity of LL-37 against Treponema denticola is dentilisin protease independent and facilitated by the major outer sheath protein virulence factor |
| Q43677044 | The role of RgpA in the pathogenicity of Porphyromonas gingivalis in the murine periodontitis model |
| Q34399545 | Transcriptional profiling of bone marrow stromal cells in response to Porphyromonas gingivalis secreted products |
| Q42104265 | Vaccination with recombinant RgpA peptide protects against Porphyromonas gingivalis-induced bone loss |
Search more.